Results 191 to 200 of about 32,249 (223)
Some of the next articles are maybe not open access.

Astrocyte truncated tropomyosin receptor kinase B mediates brain‐derived neurotrophic factor anti‐apoptotic effect leading to neuroprotection

Journal of Neurochemistry, 2018
AbstractAstrocytes are glial cells that help maintain brain homeostasis and become reactive in neurodegenerative processes releasing both harmful and beneficial factors. We have demonstrated that brain‐derived neurotrophic factor (BDNF) expression is induced by melanocortins in astrocytes but BDNF actions in astrocytes are largely unknown.
Julieta Saba   +6 more
openaire   +3 more sources

Reversible upregulation of tropomyosin-related kinase receptor B by geranylgeranoic acid in human neuroblastoma SH-SY5Y cells

Journal of Neuro-Oncology, 2011
All-trans retinoic acid (ATRA) plays crucial roles in cell survival and differentiation of neuroblastoma cells. In the present study, we investigated the effects of geranylgeranoic acid (GGA), an acyclic retinoid, on differentiation and tropomyosin-related kinase receptor B (TrkB) gene expression in SH-SY5Y human neuroblastoma cells in comparison with ...
Chiharu, Sakane, Yoshihiro, Shidoji
openaire   +2 more sources

Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies

Pharmacology & Therapeutics, 2008
The focus of this review is to critically examine and review the literature on the role of brain-derived neurotrophic factor (BDNF) and its primary receptor, tropomyosin-related kinase B (TrkB), in the actions of pharmacologically diverse antidepressant treatments for depression.
Megan E, Kozisek   +2 more
openaire   +2 more sources

Sex-dependent opposite effects of a tropomyosin-related kinase B receptor (TrkB) agonist 7,8-dihydroxyflavone on cued fear extinction in mice

Neuroscience Letters, 2020
Tropomyosin-related kinase B receptor (TrkB) is one of the new candidate receptors for drugs targeting psychiatric and neurodegenerative disorders. Recently, 7,8-dihydroxyflavone (7,8-DHF) has been identified as a selective TrkB agonist that crosses the blood-brain barrier after oral or intraperitoneal administration, and it enhances cued fear ...
Suguru Tohyama   +2 more
openaire   +2 more sources

Abstract 1142: Tropomyosin-related receptor kinase B at the invasive front of gastric cancer and tumor cell dedifferentiation

Cancer Research, 2014
Abstract Background: Tropomyosin-related receptor kinase B (TrkB) promotes proliferation and invasion related to poor prognoses of various malignancies. TrkB is also involved in resistance to anoikis (a form of detachment-induced apoptosis) and epithelial-to-mesenchymal transition (EMT).
Koji Tanaka   +13 more
openaire   +1 more source

Tropomyosin Receptor Kinase B Receptor Activation in the Locus Coeruleus Restores Impairment of Endogenous Analgesia at a Late Stage Following Nerve Injury in Rats

The Journal of Pain, 2019
A rat model of neuropathic pain at 6 weeks after spinal nerve ligation (SNL6w) exhibits both mechanical hypersensitivity and impaired noxious stimuli-induced analgesia (NSIA). Repeated treatment with antidepressants can produce antihypersensitivity and restore NSIA. To examine the involvement of a brain-derived neurotrophic factor-mediated mechanism, a
Takashi, Suto   +3 more
openaire   +2 more sources

Tropomyosin-related kinase B receptor polymorphisms and isoforms expression in suicide victims

Psychiatry Research, 2014
Federica Zarrilli   +9 more
openaire   +3 more sources

Neurotrophic Receptor, Tropomyosin-related Kinase B, as a Chemoresistant Marker in Oesophageal Cancer

Clinical Oncology, 2009
K, Tanaka   +8 more
openaire   +2 more sources

The role of tropomyosin receptor kinase type B in modulation of neuropathic pain in diabetic polyneuropathy

Journal of the Neurological Sciences, 2021
Tamara Filimonova, Yulia Karakulova
openaire   +1 more source

Home - About - Disclaimer - Privacy